Newsfeeds - Spark Newswire

2 minute read

Novamind Partners With Bienstar Wellness, Opening Door To Ibogaine Treatment For Addiction Disorders

Today, 9:58 AM

Novamind Inc. (OTCQB: NVMDF) a mental health company specializing in psychedelic medicine, recently announced a strategic investment and advisory agreement with Bienstar Wellness Corp, an Uruguay-based mental health company, to assist in the expansion of Latin Ameri

NVMDF

3 minute read

Psychedelic Companies Keenly Aware Of Creating Therapies As Healthcare Reimbursement Possibility Looms

By David Carpenter

Today, 9:58 AM

In the quest to design effective and affordable psychedelic treatments for a range of maladies that include PTSD and depression, one key thought on the minds of company executives and clinicians alike seems to be how to motivate healthcare insurance companies to cover the cost of psychedelic therapies.

FTRP

2 minute read

Psychedelic Medicine: Major Health Providers Including Blue Cross Now Cover Ketamine Treatments

By Javier Hasse

Today, 9:58 AM

Four major health insurance providers recently approved psychedelic medicine company Novamind Inc. (CSE: NM) (OTCQB: NVMDF) for direct billing of intravenous (IV) ketamine for treatment-resistant depression (TRD).

CSE:NM

5 minute read

Psyched: The 50 Publicly-listed Psychedelics Companies, Atai’s New Subsidiary, PharmaTher Gets New Orphan Drug Designation

By Natan Ponieman

Today, 9:58 AM

The Week In Psychedelics

AGNPF

2 minute read

There Are Now 50 Psychedelics Companies Listed In The U.S. – Here They Are

By Natan Ponieman

Today, 9:58 AM

Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors.

AGNPF

5 minute read

Psyched: Seattle Decriminalizes Psychedelics, Psilocybin Increases Emotions From Music, Novamind’s Palliative Care Program

By Natan Ponieman

Today, 9:58 AM

The Week In Psychedelics Seattle Decriminalizes Psychedelics Along With California City

ABBV

2 minute read

Psychedelic Medicine For End-Of-Life And Palliative Care Patients: Novamind Launches Treatment Program

By Natan Ponieman

Today, 9:58 AM

Novamind (Canadian: NM) (OTCQB: NVMDF), a company in the psychedelics space that operates several mental health clinics in Utah, announced a new program for palliative care patients experiencing chronic and serious illnesses.

NVMDF

5 minute read

Psyched: Elon Musk Discusses Psychedelics, Delix Raises $70M, MindCure To Study MDMA In Female Sexual Dysfunction

By Natan Ponieman

Today, 9:58 AM

The Week In Psychedelics:

$DOGE

7 minute read

Meet The Top 12 CEOs In The Psychedelics Industry

By Natan Ponieman

Today, 9:58 AM

By Natan Ponieman and Javier Hasse The psychedelic medicine industry is growing by leaps and bounds. Leading this charge is a group of ambitious and visionary corporate leaders, working to create new methods for the treatment of mental health and other serious conditions.

ATAI

4 minute read

Psyched: Atai’s $214M IPO, MindMed CEO Resigns, Field Trip Applies To Nasdaq, Cybin And Novamind Target Frontline Health Workers

By Natan Ponieman

Today, 9:58 AM

Atai Launches $214 Million Nasdaq IPO Offering Psychedelics biotech platform Atai life Sciences has announced an initial public offering of approximately 14 million of its common shares, ahead of the company’s expected Nasdaq listing.

CLXPF